Drug-coated Balloon Treatment

NCT07794839 | Recruiting

• 1 other identifier: DCB TURK
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

Evaluation of the efficacy and clinical outcomes of drug-eluting balloon therapy in ticyaici coronary artery disease.

Conditions

Coronary Artery Disease

Keywords

drug coated balloon; drug eluting stent

Outcome Measures

Primary Outcomes (1)

• target lesion failure

  composite endpoint of target lesion revascularization, target vessel myocardial infarction and cardiac death

  12 month

Study Arms (2)

drug coated balloon

lesions treated with drug coated balloon

Device: drug coated balloon

drug eluting stent

lesions treated with drug eluting stent

Device: drug eluting stent

Interventions

drug coated balloon DEVICE

patients treated with drug coated balloon dilatation

drug coated balloon

drug eluting stent DEVICE

patients treated with drug eluting stent implantation

drug eluting stent

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

coronary artery lesions treated with drug coated balloon dilatation or drug eluting stent implantation

Sponsors & Collaborators

• Istanbul Mehmet Akif Ersoy Educational and Training Hospital: lead

Study Sites (1)

University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology

Istanbul, Turkey (Türkiye)

RECRUITING

Related Publications (3)

• Shin D, Singh M, Shlofmitz E, Scheller B, Latib A, Kandzari DE, Zaman A, Mylotte D, Dakroub A, Malik S, Sakai K, Jeremias A, Moses JW, Shlofmitz RA, Stone GW, Ali ZA. Paclitaxel-coated versus sirolimus-coated balloon angioplasty for coronary artery disease: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2024 Sep;104(3):425-436. doi: 10.1002/ccd.31154. Epub 2024 Jul 24.

  PMID: 39044661 RESULT

• Fezzi S, Serruys PW, Cortese B, Scheller B, Alfonso F, Jeger R, Colombo A, Joner M, Shin ES, Kleber F, Latib A, Rissanen TT, Eccleshall S, Ribichini F, Tao L, Koo BK, Chieffo A, Ge J, Granada JF, Stoll HP, Spaulding C, Cavalcante R, Abizaid A, Muramatsu T, Boudoulas KD, Waksman R, Mehran R, Cutlip D, Krucoff M, Stone GW, Garg S, Onuma Y. Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement. J Am Coll Cardiol. 2025 Oct 14;86(15):1170-1202. doi: 10.1016/j.jacc.2025.07.049.

  PMID: 41062231 RESULT

• Camaj A, Leone PP, Colombo A, Vinayak M, Stone GW, Mehran R, Dangas G, Kini A, Sharma SK. Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review. JAMA Cardiol. 2025 Feb 1;10(2):189-198. doi: 10.1001/jamacardio.2024.4244.

  PMID: 39714903 RESULT

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Drug-Eluting Stents

Condition Hierarchy (Ancestors)

Coronary Disease; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases

Intervention Hierarchy (Ancestors)

Stents; Prostheses and Implants; Equipment and Supplies

Central Study Contacts

SERKAN KAHRAMAN, PROF, MD

CONTACT

+905053825921; serkankahraman_86@outlook.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Profesor, MD

Study Record Dates

• First Submitted: August 26, 2026
• First Posted: August 31, 2026
• Study Start: January 1, 2026
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): April 1, 2027
• Last Updated: August 31, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)